ID   OV266
AC   CVCL_A405
SY   Ov266; ov266; OV 266
DR   Cosmic; 845147
DR   Wikidata; Q54936889
RX   PubMed=9473353;
RX   PubMed=9625810;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=9473353; DOI=10.1006/excr.1997.3861;
RA   Conover, Cheryl A.
RA   Hartmann, Lynn C.
RA   Bradley, Sarah V.
RA   Stalboerger, Paul G.
RA   Klee, George G.
RA   Kalli, Kimberly R.
RA   Jenkins, Robert Brian
RT   "Biological characterization of human epithelial ovarian carcinoma
RT   cells in primary culture: the insulin-like growth factor system.";
RL   Exp. Cell Res. 238:439-449(1998).
//
RX   PubMed=9625810; DOI=10.3892/ijo.13.1.101;
RA   Yokomizo, Akira
RA   Tindall, Donald J.
RA   Hartmann, Lynn C.
RA   Jenkins, Robert Brian
RA   Smith, David I.
RA   Liu, Wan-Guo
RT   "Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in
RT   human ovarian cancer.";
RL   Int. J. Oncol. 13:101-105(1998).
//